AGO2 and melanoma: To determine which role AGO2-ex1/3 expression plays in melanoma cells, we designed an siRNA (siAGO2-ex1/3) that specifically targets the mRNA of the AGO2-ex1/3 splice variant at the junction between exon1 and exon3.